Plasma neurofilament light outperforms glial fibrillary acidic protein in differentiating behavioural variant frontotemporal dementia from primary psychiatric disorders

This study found elevated GFAP levels in bvFTD compared to a large cohort of PPD, but NfL levels exhibited better performance in this distinction. These findings extend the literature on GFAP in bvFTD and build evidence for plasma NfL as a useful biomarker to assist with distinguishing bvFTD from PPD. Utilisation of NfL may improve timely and accurate diagnosis of bvFTD.

Authors

Institutions

Publication Details

Journal
Journal of the Neurological Sciences
Published
2024-11-08
DOI
https://doi.org/10.1016/j.jns.2024.123291
Citations
11
Primary Topic
Amyotrophic Lateral Sclerosis Research
Type
article
Field-Weighted Citation Impact
4.06
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Plasma neurofilament light outperforms glial fibrillary acidic protein in differentiating behavioural variant frontotemporal dementia from primary psychiatric disorders

Charles Benjamin Malpas, David Darby, Christos Pantelis, Naveen Thomas et al.
11 citations
Journal of the Neurological Sciences
Amyotrophic Lateral Sclerosis Research
4.06
article

Plasma neurofilament light outperforms glial fibrillary acidic protein in differentiating behavioural variant frontotemporal dementia from primary psychiatric disorders

Charles Benjamin Malpas, David Darby, Christos Pantelis, Naveen Thomas, Kaj Blennow, Claudia Cicognola, Olivia Dean, Amy G. Brodtmann, Oskar Hansson, Ian Everall, Christa Dang, Matthew Kang, Dhamidhu Eratne, Dennis Velakoulis, Michael Berk, Henrik Zetterberg, Suyi Ooi, Shorena Janelidze, Cassandra M. J. Wannan, Alexander Santillo, Chad Bousman, Courtney Lewis
article en
11 citations

Abstract

This study found elevated GFAP levels in bvFTD compared to a large cohort of PPD, but NfL levels exhibited better performance in this distinction. These findings extend the literature on GFAP in bvFTD and build evidence for plasma NfL as a useful biomarker to assist with distinguishing bvFTD from PPD. Utilisation of NfL may improve timely and accurate diagnosis of bvFTD.

Journal of the Neurological SciencesVol. 467
The Royal Melbourne Hospital (AU), Box Hill Hospital (AU), Deakin University (AU), The University of Melbourne (AU), University of Calgary (CA), King's College London (GB), Lund University (SE), Florey Institute of Neuroscience and Mental Health (AU), National Ageing Research Institute (AU), Orygen Youth Health (AU), Western Health (AU), Sunshine Hospital (AU), Molecular Research Institute (US), University College London (GB), University of Gothenburg (SE)
Good health and well-being
Openalex Percentile: Top 5%
Amyotrophic Lateral Sclerosis Research
4.06
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.